BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

346 related articles for article (PubMed ID: 25821210)

  • 1. Patient dosimetry in nuclear medicine.
    Mattsson S
    Radiat Prot Dosimetry; 2015 Jul; 165(1-4):416-23. PubMed ID: 25821210
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Three-dimensional radiobiologic dosimetry: application of radiobiologic modeling to patient-specific 3-dimensional imaging-based internal dosimetry.
    Prideaux AR; Song H; Hobbs RF; He B; Frey EC; Ladenson PW; Wahl RL; Sgouros G
    J Nucl Med; 2007 Jun; 48(6):1008-16. PubMed ID: 17504874
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DOSIS: An integrated computational tool for patient-specific dosimetry in nuclear medicine by Monte Carlo and dose point kernel approaches.
    Pérez P; Valente M
    Appl Radiat Isot; 2019 Aug; 150():135-140. PubMed ID: 31146217
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TestDose: A nuclear medicine software based on Monte Carlo modeling for generating gamma camera acquisitions and dosimetry.
    Garcia MP; Villoing D; McKay E; Ferrer L; Cremonesi M; Botta F; Ferrari M; Bardiès M
    Med Phys; 2015 Dec; 42(12):6885-94. PubMed ID: 26632045
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of internal dose estimates obtained using organ-level, voxel S value, and Monte Carlo techniques.
    Grimes J; Celler A
    Med Phys; 2014 Sep; 41(9):092501. PubMed ID: 25186410
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 3D calculation of absorbed dose for 131I-targeted radiotherapy: a Monte Carlo study.
    Saeedzadeh E; Sarkar S; Abbaspour Tehrani-Fard A; Ay MR; Khosravi HR; Loudos G
    Radiat Prot Dosimetry; 2012 Jul; 150(3):298-305. PubMed ID: 22069233
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Personalized dosimetry of
    Carter LM; Ocampo Ramos JC; Kesner AL
    Biomed Phys Eng Express; 2021 Aug; 7(5):. PubMed ID: 34271565
    [No Abstract]   [Full Text] [Related]  

  • 8. Accurate dosimetry in 131I radionuclide therapy using patient-specific, 3-dimensional methods for SPECT reconstruction and absorbed dose calculation.
    Dewaraja YK; Wilderman SJ; Ljungberg M; Koral KF; Zasadny K; Kaminiski MS
    J Nucl Med; 2005 May; 46(5):840-9. PubMed ID: 15872359
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of the FLUKA Monte Carlo code for 3D patient-specific dosimetry on PET-CT and SPECT-CT images.
    Botta F; Mairani A; Hobbs RF; Vergara Gil A; Pacilio M; Parodi K; Cremonesi M; Coca Pérez MA; Di Dia A; Ferrari M; Guerriero F; Battistoni G; Pedroli G; Paganelli G; Torres Aroche LA; Sgouros G
    Phys Med Biol; 2013 Nov; 58(22):8099-120. PubMed ID: 24200697
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of respiratory motion on internal radiation dosimetry.
    Xie T; Zaidi H
    Med Phys; 2014 Nov; 41(11):112506. PubMed ID: 25370665
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Implementation and evaluation of patient-specific three-dimensional internal dosimetry.
    Kolbert KS; Sgouros G; Scott AM; Bronstein JE; Malane RA; Zhang J; Kalaigian H; McNamara S; Schwartz L; Larson SM
    J Nucl Med; 1997 Feb; 38(2):301-8. PubMed ID: 9025759
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Three-dimensional patient-specific dosimetry in radioimmunotherapy with 90Y-ibritumomab-tiuxetan.
    D'Arienzo M; Cicone F; Chiacchiararelli L; Coniglio A; Delaloye AB; Scopinaro F
    Cancer Biother Radiopharm; 2012 Mar; 27(2):124-33. PubMed ID: 22283680
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of PET and SPECT on dosimetry for targeted radionuclide therapy.
    Flux G; Bardies M; Monsieurs M; Savolainen S; Strands SE; Lassmann M;
    Z Med Phys; 2006; 16(1):47-59. PubMed ID: 16696370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative dosimetry for yttrium-90 radionuclide therapy: tumor dose predicts fluorodeoxyglucose positron emission tomography response in hepatic metastatic melanoma.
    Eaton BR; Kim HS; Schreibmann E; Schuster DM; Galt JR; Barron B; Kim S; Liu Y; Landry J; Fox T
    J Vasc Interv Radiol; 2014 Feb; 25(2):288-95. PubMed ID: 24269792
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 90Y PET-based dosimetry after selective internal radiotherapy treatments.
    D'Arienzo M; Chiaramida P; Chiacchiararelli L; Coniglio A; Cianni R; Salvatori R; Ruzza A; Scopinaro F; Bagni O
    Nucl Med Commun; 2012 Jun; 33(6):633-40. PubMed ID: 22407156
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Minimizing and communicating radiation risk in pediatric nuclear medicine.
    Fahey FH; Treves ST; Adelstein SJ
    J Nucl Med; 2011 Aug; 52(8):1240-51. PubMed ID: 21764783
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Strategies for CT tissue segmentation for Monte Carlo calculations in nuclear medicine dosimetry.
    Braad PE; Andersen T; Hansen SB; Høilund-Carlsen PF
    Med Phys; 2016 Dec; 43(12):6507. PubMed ID: 27908147
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative analysis of 90Y Bremsstrahlung SPECT-CT images for application to 3D patient-specific dosimetry.
    Fabbri C; Sarti G; Cremonesi M; Ferrari M; Di Dia A; Agostini M; Botta F; Paganelli G
    Cancer Biother Radiopharm; 2009 Feb; 24(1):145-54. PubMed ID: 19243257
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pretreatment CLR 124 Positron Emission Tomography Accurately Predicts CLR 131 Three-Dimensional Dosimetry in a Triple-Negative Breast Cancer Patient.
    Besemer AE; Grudzinski JJ; Weichert JP; Hall LT; Bednarz BP
    Cancer Biother Radiopharm; 2019 Feb; 34(1):13-23. PubMed ID: 30351218
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patient-specific dosimetry for 131I thyroid cancer therapy using 124I PET and 3-dimensional-internal dosimetry (3D-ID) software.
    Sgouros G; Kolbert KS; Sheikh A; Pentlow KS; Mun EF; Barth A; Robbins RJ; Larson SM
    J Nucl Med; 2004 Aug; 45(8):1366-72. PubMed ID: 15299063
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.